BeOne Medicines Expands US Manufacturing With Total Investment Of More Than $1 Billion To Advance Innovative Cancer Medicines
ONC•Jobs and timeline
The expansion is expected to create 120 new full-time jobs in the U.S.
BeOne Medicines said the expanded facility is expected to be fully operational in 2029.
BeOne Medicines expands U.S. manufacturing investment
BeOne Medicines AG said it is expanding its U.S. manufacturing with a total investment of more than $1 billion to advance innovative cancer medicines.
The company also announced a $300 million expansion of its Hopewell, New Jersey, manufacturing center.
